Arthritis, Rheumatoid Arthritis
Conditions
Keywords
Rheumatoid Arthritis, Mobile Health, Pain, Arthritis
Brief summary
The overall objective of this proposal is to implement a smart phone application (app) + population management system to monitor rheumatoid arthritis (RA) disease activity between scheduled physician office visits. The population management system includes: 1) a web-based dashboard that consolidates incoming patient-reported data using pre-programmed algorithms to identify increases in disease activity, and 2) the population manager, a trained individual who monitors the web-based dashboard and connects patients with their healthcare providers (HCPs). The investigators central hypothesis is that the combined smart phone app + population management system will improve patient satisfaction and management of RA disease activity.
Interventions
OTHERMobile Application
A mobile health application that asks daily questions about participants' pain, function, and disease activity.
OTHERPopulation Management System
Study staff will act as care managers behind a web-based dashboard to monitor participants' responses to the daily questions on the mobile application and connect them with their HCPs.
Sponsors
Pfizer
Brigham and Women's Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of RA by a board-certified rheumatologist * Taking a DMARD (sulfasalazine, methotrexate, leflunomide, azathioprine, certolizumab, cyclosporine, adalimumab, etanercept, infliximab, golimumab, abatacept, tocilizumab, anakinra, tofacitinib, rituximab, hydroxychloroquine) * Own a smart phone with either an Android or iPhone operating system * Be English-speaking
Exclusion criteria
* Patients who do not plan on receiving follow-up care at the Brigham and Women's Hospital Arthritis Center
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment Satisfaction Questionnaire for Medication (TSQM) | 6 months |
| Clinical Disease Activity Index (CDAI) | 6 months |
| Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI) | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Patient Activity Scale-II (PAS-II) | 6 months |
| Flare Assessment in Rheumatoid Arthritis (FLARE) questionnaire | 6 months |
Countries
United States
Outcome results
None listed